Monthly Archives: September, 2016

Interview and Video with Emeran Mayer, MD of UCLA on the Gut-Brain-Microbiome Connection in IBS

Earlier this month, WBUR, the Boston affiliate of National Public Radio published a recent interview with Emeran Mayer, MD, Director of the University of California/Los Angeles Oppenheimer Center for Neurobiology of Stress and Resilience, a leading research center for irritable bowel syndrome and other neurologically-based chronic pain conditions. Dr. Mayer also recently published a book …

Continue reading

Virtus Pharmaceuticals Initiates Voluntary Recall of Some U.S. Hyoscyamine Tablets -Sept. 2016

IBS Impact has recently learned of a voluntary recall of some batches of some forms of hyoscyamine tablets distributed by Virtus Pharmaceuticals. Hyoscyamine (Levsin, Levbid and other various brand names) is an anticholernergic agent prescribed for some adults and children with IBS or related functional gastrointestinal disorders. As this is a generic medication, not all …

Continue reading